Literature DB >> 6317144

[3H]TCP: a new tool with high affinity for the PCP receptor in rat brain.

J Vignon, R Chicheportiche, M Chicheportiche, J M Kamenka, P Geneste, M Lazdunski.   

Abstract

PCP binding sites have previously been demonstrated in the central nervous system with [3H]PCP. We now describe the binding properties to rat brain membranes of [3H]TCP, a PCP derivative. It is very advantageous to use [3H]TCP instead of [3H]PCP for the 3 following reasons: (i) it has a better affinity (Kd = 7.4 nM) for PCP binding sites than PCP itself; (ii) it dissociates slowly from its binding sites (t 1/2 = 20 min); (iii) the non-specific binding component obtained with [3H]TCP is much lower than that found with [3H]PCP.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6317144     DOI: 10.1016/0006-8993(83)91193-9

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  11 in total

1.  Pharmacological characterization of RP 62203, a novel 5-hydroxytryptamine 5-HT2 receptor antagonist.

Authors:  A Doble; D Girdlestone; O Piot; D Allam; J Betschart; A Boireau; A Dupuy; C Guérémy; J Ménager; J L Zundel
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Inhibition of (+)[3H]SKF 10,047 binding to rat brain membranes by FAB fragments from a monoclonal antibody directed against the opioid receptor.

Authors:  C B Tyler; J M Bidlack
Journal:  Neurochem Res       Date:  1988-08       Impact factor: 3.996

3.  Discriminative stimulus properties of (+)-N-allylnormetazocine in the rat: correlations with (+)-N-allylnormetazocine and phencyclidine receptor binding.

Authors:  G F Steinfels; S W Tam; L Cook
Journal:  Psychopharmacology (Berl)       Date:  1987       Impact factor: 4.530

4.  Effects of membrane fluidity on [3H]TCP binding to PCP receptors.

Authors:  F R DePietro; J C Byrd
Journal:  J Mol Neurosci       Date:  1990       Impact factor: 3.444

5.  Conformational preferences of the potent dopamine reuptake blocker BTCP and its analogs and their incorporation into a pharmacophore model.

Authors:  M Froimowitz; K M Wu; J Rodrigo; C George
Journal:  J Comput Aided Mol Des       Date:  2000-02       Impact factor: 3.686

6.  Phencyclidine treatment in mice: effects on phencyclidine binding sites and glutamate uptake in cerebral cortex preparations.

Authors:  P Saransaari; S M Lillrank; S S Oja
Journal:  J Neural Transm Gen Sect       Date:  1993

7.  Postnatal changes in N-methyl-D-aspartate receptor binding and stimulation by glutamate and glycine of [3H]-MK-801 binding in human temporal cortex.

Authors:  P Slater; S E McConnell; S W D'Souza; A J Barson
Journal:  Br J Pharmacol       Date:  1993-04       Impact factor: 8.739

8.  Role of the sigma receptor in the inhibition of [3H]-noradrenaline uptake in brain synaptosomes and adrenal chromaffin cells.

Authors:  C Rogers; S Lemaire
Journal:  Br J Pharmacol       Date:  1991-08       Impact factor: 8.739

9.  Phencyclidine binds to blood platelets with high affinity and specifically inhibits their activation by adrenaline.

Authors:  G A Jamieson; A K Agrawal; N J Greco; T E Tenner; G D Jones; K C Rice; A E Jacobson; J G White; N N Tandon
Journal:  Biochem J       Date:  1992-07-01       Impact factor: 3.857

10.  MPTP lesions of the nigrostriatal dopaminergic projection decrease [3H]1-[1-(2-thienyl)cyclohexyl]piperidine binding to PCP site 2: further evidence that PCP site 2 is associated with the biogenic amine reuptake complex.

Authors:  H C Akunne; J N Johannessen; B R de Costa; K C Rice; R B Rothman
Journal:  Neurochem Res       Date:  1992-03       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.